We previously reported that c-MET or platelet-derived growth factor receptor α (PDGFRα) signalling pathway was relevant for SS progression, based upon the findings of phospho-receptor tyrosine kinase (RTK) arrays [8]. The gene discussed is NTRK1; the disease is synovial sarcoma.